For Immediate Release
Chicago, IL – November 18, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Wells Fargo & Company (
WFC Quick Quote WFC - Free Report) , Honeywell International Inc. ( HON Quick Quote HON - Free Report) , Northrop Grumman Corporation ( NOC Quick Quote NOC - Free Report) , The Travelers Companies, Inc. ( TRV Quick Quote TRV - Free Report) and GSK plc ( GSK Quick Quote GSK - Free Report) . Here are highlights from Thursday’s Analyst Blog: Top Stock Reports for Wells Fargo, Honeywell and Northrop Grumman
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Wells Fargo & Company, Honeywell International Inc. and Northrop Grumman Corporation. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
see all of today’s research reports here >>> Wells Fargo shares have outperformed the Zacks Banks - Major Regional industry over the past six-month period (+9.7% vs. +5.2%). The Zacks analyst believes that the company’s progress on efficiency initiatives propelled expense control and savings, which are likely to support its bottom line in the upcoming period. Strength in the deposit balance will aid the bank’s liquidity position. The company’s solid liquidity position will help to meet its debt obligations if the economic situation worsens. Also, capital deployment activities seem sustainable.
However, due to legal hassles, Wells Fargo has been penalized with business restrictions and a monetary fine. Restrictions on asset growth will continue to limit loan expansion ability. A decline in originations might limit mortgage banking income.
) read the full research report on Wells Fargo here >>> Honeywell International shares have gained +2.7% over the year-to-date period against the Zacks Diversified Operations industry’s loss of -16.1%. The Zacks analyst believes that healthy demand, orders and backlog bode well for Honeywell’s growth. Recovery in commercial flight hours is driving revenues at the Aerospace segment, while the Building Technologies segment is benefiting from commercial actions and strength in building products and building solutions. The company’s measures to reward its shareholders through dividends and share buybacks are encouraging.
However, supply chain constraints, labor market challenges and inflationary pressures are hurting the company’s operations. Weakness in the Safety and Productivity Solutions sales due to lower personal protective equipment and warehouse automation volume is an added concern. Also, adverse foreign currency movements are affecting the company’s bottom line.
) read the full research report on Honeywell International here >>> Northrop Grumman shares have outperformed the Zacks Aerospace - Defense industry over the year-to-date period (+30.5% vs. -1.6%). The Zacks analyst believes that Northrop Grumman has developed into one of the top largest U.S. defense contractors in terms of revenues, with a major platform-centric focus. It continues to witness strong demand for its products, driven by programs like the F-35, Triton and SABR radar Global Hawk and the E-2D program. Solid U.S. budgetary provisions make one confident about a solid inflow of contracts from the Pentagon for it. It also holds a strong solvency position, at least in the short term. Its shares have outperformed the industry in the past year.
However, a comparative analysis of the stock’s trailing 12-month EV/Sales ratio reflects a relatively gloomy picture that might be a cause of concern. It fears that the continued spread of COVID-19 may cause extended disruption in its supply chain.
) read the full research report on Northrop Grumman here >>>
Other noteworthy reports we are featuring today include The Travelers Companies, Inc. and GSK plc.
Why Haven’t You Looked at Zacks' Top Stocks?
Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared
+40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation. See Stocks Free >>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss
. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.